Revenue up 19% but NPAT fell 35% and the interim dividend was cut 40%

What changed

Revenue from continuing operations rose 19% to NZ$12.9m (HY25: NZ$10.8m), extending the growth profile seen in HY25. Despite that top-line gain, net profit after tax fell 35.3% to NZ$1.0m from NZ$1.6m. The release attributes the decline primarily to around NZ$0.6m of exceptional expenses in the first half. The interim dividend was cut 39.6% to 0.332 cents per share (NZ$305,017 in total, stated as 30% of NPAT), versus 0.55 cents in HY25. Total assets grew 47.2% to NZ$275.8m against HY25's NZ$187.4m, pointing to continued lending-book expansion, though current-period cash, borrowings and equity were not disclosed in the excerpts.

What matters

• Earnings quality pivot. Revenue and balance-sheet scale both grew materially, yet NPAT fell. If the NZ$0.6m of flagged exceptional costs is genuinely one-off, underlying NPAT would be closer to NZ$1.6m — roughly flat on HY25 — but the release does not provide an adjusted figure or a formal reconciliation.
• Dividend signal. The payout was cut proportionally more than earnings (−39.6% vs −35.3% NPAT), and at 30% of NPAT it tightens the payout ratio relative to HY25's disclosed cents-per-share level. This reads as a capital-retention decision consistent with the 47% asset-base expansion.
• Balance-sheet direction undisclosed. With total assets up NZ$88.4m but HY26 liabilities, equity, cash and gross borrowings all absent from the excerpts, leverage direction cannot be assessed — a critical gap for a lender-type issuer.

Expectations

No quantified guidance or forward-work target was disclosed. Against the HY25/FY25 shape (FY25 revenue NZ$22.6m, FY25 NPAT NZ$2.8m), HY25 captured roughly 48% of FY25 revenue and 56% of FY25 NPAT, implying a modestly first-half-weighted earnings profile. HY26 revenue of NZ$12.9m already exceeds the implied 2H25 run-rate of ~NZ$11.8m, so the top line is tracking ahead. NPAT of NZ$1.0m, however, is below the implied 2H25 NPAT of ~NZ$1.2m, so the earnings line is not. The release does not support a statement about whether the exceptional costs reverse in 2H26.

Quality of result

The result mixes durable and timing-driven elements. The 19% revenue gain and 47% asset-base growth point to genuine book expansion. The earnings shortfall is described as exceptional rather than structural, but without a disclosed adjusted NPAT, PBT, tax expense, or operating cash flow for HY26, the durability claim rests on management narrative alone. The prior-period effective tax rate was 28.7%; with no HY26 PBT or tax disclosed, the cleaner operating read (PBT growth) cannot be computed. Cash conversion cannot be evaluated because operating cash flow was not provided.

Unresolved

• What was HY26 profit before tax, income tax expense, and operating cash flow, and how do they reconcile to the 35% NPAT decline?
• What is the HY26 composition of total liabilities, borrowings and equity behind the NZ$88.4m asset increase, and what is the current leverage ratio?
• What specifically comprised the NZ$0.6m of exceptional expenses, and are any residual costs expected to flow into 2H26?
• Why was the dividend cut by a larger percentage than NPAT if the earnings weakness is framed as one-off?
• Was any impairment, provisioning change, or funding-cost movement a contributor alongside the flagged exceptionals?

This briefing cannot assess underlying profitability, leverage, or cash quality because HY26 PBT, tax, operating cash flow and full balance-sheet line items were not provided in the supplied extract.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.